News

Eli Lilly launches Mounjaro pen in India

Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry
Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees (nearly $160) for its starting dose of 2.5 mg in India, stepping up competition with Novo Nordisk.
Eli Lilly launches Mounjaro KwikPen for diabetes and obesity in India – Check doses, prices and how it works
Eli Lilly launches Mounjaro KwikPen in India, offering adults with type 2 diabetes and obesity a once-weekly, prescription-only treatment.
Lilly launches Mounjaro pen in India priced at $160
Eli Lilly launches injector pen for Mounjaro in India, Reuters reports
Eli Lilly (LLY) launched an injector pen for Mounjaro, its weight-loss drug, for 14,000 rupees, or $160, for its starting dose in India, Rishika
Eli Lilly launches Mounjaro pen in India as obesity drug race heats up
Eli Lilly has rolled out a prefilled pen version of its weight-loss drug Mounjaro at the same price as vials, aiming to capture India’s growing anti-obesity market as Novo Nordisk pushes Wegovy.
Eli Lilly begins commercial rollout of Mounjaro pen in India
Eli Lilly (NYSE:LLY) debuted its best-selling diabetes therapy, Mounjaro, in an easy-to-use injector format in India on Wednesday, escalating a rivalry with Novo Nordisk (NVO) in the world’s most populous country.

Eli Lilly First to Use Germany’s New Confidential Pricing for Mounjaro

Eli Lilly and Company (NYSE: LLY) is one of the best upside stocks to invest in now. On August 11, Eli Lilly announced its ...

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar

Eli Lilly hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its ...

Eli Lilly: The Bears Have Spoken Loud And Clear (Upgrade)

Eli Lilly and Company faces valuation pressure after disappointing Orforglipron results. Click here to read an analysis of ...

Eli Lilly weight loss pill shows promise in latest clinical trial, company says

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...

Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers’ first choice for patients with Type ...